Tenet Healthcare Corporation $THC Shares Sold by Inspire Investing LLC

Inspire Investing LLC decreased its position in Tenet Healthcare Corporation (NYSE:THC) by 17.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,106 shares of the company’s stock after selling 1,050 shares during the quarter. Inspire Investing LLC’s holdings in Tenet Healthcare were worth $899,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in Tenet Healthcare during the 1st quarter valued at $26,000. Wayfinding Financial LLC acquired a new position in shares of Tenet Healthcare in the 1st quarter worth $28,000. SVB Wealth LLC acquired a new position in shares of Tenet Healthcare in the 1st quarter worth $30,000. N.E.W. Advisory Services LLC acquired a new position in shares of Tenet Healthcare in the 1st quarter worth $31,000. Finally, Brooklyn Investment Group grew its holdings in shares of Tenet Healthcare by 908.7% during the first quarter. Brooklyn Investment Group now owns 232 shares of the company’s stock valued at $31,000 after buying an additional 209 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. KeyCorp lifted their price target on Tenet Healthcare from $205.00 to $225.00 and gave the company an “overweight” rating in a report on Wednesday. Robert W. Baird reduced their price target on Tenet Healthcare from $195.00 to $167.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. UBS Group boosted their price objective on Tenet Healthcare from $230.00 to $238.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Zacks Research cut Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Finally, Guggenheim upped their price target on Tenet Healthcare from $180.00 to $188.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $201.69.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Lisa Y. Foo sold 8,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total value of $1,436,240.00. Following the transaction, the executive vice president directly owned 20,878 shares in the company, valued at approximately $3,748,227.34. This trade represents a 27.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Christopher S. Lynch sold 3,952 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $176.39, for a total value of $697,093.28. Following the completion of the transaction, the director directly owned 12,358 shares in the company, valued at approximately $2,179,827.62. This trade represents a 24.23% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 90,722 shares of company stock worth $17,161,015. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Down 2.8%

NYSE THC opened at $189.45 on Friday. The firm has a market cap of $16.74 billion, a PE ratio of 12.13, a price-to-earnings-growth ratio of 0.81 and a beta of 1.52. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $207.14. The stock’s 50 day simple moving average is $185.76 and its 200 day simple moving average is $164.87. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.71 and a quick ratio of 1.63.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 EPS for the quarter, topping analysts’ consensus estimates of $2.84 by $1.18. The business had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%.Tenet Healthcare’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $2.31 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. As a group, sell-side analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.